Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy.
about
Productivity losses associated with cardiovascular disease: a systematic review.Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden.A review of health utilities using the EQ-5D in studies of cardiovascular disease.Health economic consequences of reducing salt intake and replacing saturated fat with polyunsaturated fat in the adult Finnish population: estimates based on the FINRISK and FINDIET studiesCost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension.Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model.Economic evaluation of plerixafor for stem cell mobilization.Revisiting rose: comparing the benefits and costs of population-wide and targeted interventions.Does a hospital admission in old age denote the beginning of life with a compromised health-related quality of life? A longitudinal study of men and women aged 65 years and above participating in the Stockholm Public Health CohortCost-effectiveness of statins revisited: lessons learned about the value of innovation.A systematic literature review of cardiovascular event utilities.COST-EFFECTIVENESS OF TREATMENTS FOR MILD-TO-MODERATE OBSTRUCTIVE SLEEP APNEA IN FRANCE.Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder.Utility loss and indirect costs after stroke in Sweden.Cost effectiveness of a pharmacist-led information technology intervention for reducing rates of clinically important errors in medicines management in general practices (PINCER).A cost-effectiveness analysis of a community based CVD program in Sweden based on a retrospective register cohort.
P2860
Q30241494-AB4CD609-F053-4B5B-98A6-311D622A97D3Q31028191-210FB9B1-9708-4CF2-9F38-A9475819F8E1Q33669647-7369A55F-C91D-41EB-96C2-8528BCC13032Q35294920-03B8432F-DE03-4338-81E4-5ACA171F69B4Q36383863-6FE4A51F-98F9-4469-B645-4185BAA2CB5EQ36530069-647FD0B6-7E78-49F9-BC40-B833FC720124Q36831799-26287851-14C8-4D0C-9A04-5B374685CB89Q37039321-A164545A-CE69-4BE9-9AD4-4BDDE7510657Q37100937-40495931-1E1B-485E-9E22-B0914B322774Q37870094-370B764E-E793-4307-92DE-517A475B998CQ38157041-775B5B5F-6200-4A83-B7FE-29BB445E1840Q40865077-2E1120B4-4E02-4BB7-ACE2-AC1C61838DBEQ46152573-87BC57C8-F7E5-4CAD-B63F-41E195DB9604Q53151762-330EC6CB-F938-4F3A-A1DF-228E9182B8CAQ53290843-CE8D1987-12BE-4B62-9E44-4521E6F83115Q55068358-01AC1911-3F6D-4451-A91E-5DEC9274DB01
P2860
Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Utility loss and indirect cost ...... SCOT health economic substudy.
@en
type
label
Utility loss and indirect cost ...... SCOT health economic substudy.
@en
prefLabel
Utility loss and indirect cost ...... SCOT health economic substudy.
@en
P2093
P1476
Utility loss and indirect cost ...... SCOT health economic substudy.
@en
P2093
ASCOT investigators
Bengt Jonsson
Martin Buxton
Neil Poulter
Patrick Svarvar
Thomas Kahan
P2888
P356
10.1007/S10198-006-0002-9
P577
2007-03-01T00:00:00Z